PTGS2 and cancer: Recently, cytotoxic therapy has been shown to acutely enhance COX-2 transcription and PGE2 production in cancer cells, which modifies the tumoral inflammatory response and the efficacy of cytotoxic- and immuno-therapies, although such responses are only observed in tumors with prior activation of the pathway and basal levels of COX-2 mRNA [15].